The CD47 “don't eat me signal” is highly expressed in human ovarian cancer-Reference-Cited by-同舟云学术

The CD47 “don't eat me signal” is highly expressed in human ovarian cancer

Published:2016-11 Issue:2 Volume:143 Page:393-397
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Brightwell R.M.,Grzankowski K.S.,Lele S.,Eng K.,Arshad M.,Chen H.,Odunsi K.

Funder

Cancer Research Institute

Ludwig Institute for Cancer Research

Ovarian Cancer Research Fund

Roswell Park Alliance Foundation

NCI

NIH

RPCI-UPCI

NYSTEM

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference16 articles.

1. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis;Jaiswal;Cell,2009

2. The CD47-signal regulatory protein alpha (SIRP α) interaction is a therapeutic target for human solid tumors;Willingham;Proc. Natl. Acad. Sci.,2012

3. CD47: acell surface glycoprotein which regulates multiple functions of hematopoietic cells in health and disease;Olenborg;International Scholarly Research Notices,2013

4. CD47 protein expression in acute myeloid leukemia: a tissue microarray-based analysis;Gali;Leuk. Res.,2015

5. Role of CD47 in erythroid cells and in autoimmunity;Olenborg;Leuk. Lymphoma,2004

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach;Nature Reviews Clinical Oncology;2024-09-04

2. The biological roles of CD47 in ovarian cancer progression;Cancer Immunology, Immunotherapy;2024-06-04

3. LncRNA IL21-AS1 facilitates tumour progression by enhancing CD24-induced phagocytosis inhibition and tumorigenesis in ovarian cancer;Cell Death & Disease;2024-05-03

4. Spatial distribution of tumor‐resident macrophages as predictive biomarkers in endometrial cancer;Journal of Obstetrics and Gynaecology Research;2024-04-16

5. Macrophage Checkpoint Nanoimmunotherapy Has the Potential to Reduce Malignant Progression in Bioengineered In Vitro Models of Ovarian Cancer;ACS Applied Bio Materials;2024-04-01